CoChat

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

Open access
Tuo, Lin, Xiang, Jin, Pan, Xuanming, Hu, Jieli, Tang, Hua, Liang, Li, Xia, Jie, Hu, Yuan, Zhang, Wenlu, Huang, Ailong, Wang, Kai, Tang, Ni · 2019 · Journal of Experimental & Clinical Cancer Research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Altered glucose metabolism endows tumor cells with metabolic flexibility for biosynthesis requirements. Phosphoenolpyruvate carboxykinase 1 (PCK1), a key enzyme in the gluconeogenesis pathway, is downregulated in hepatocellular carcinoma (HCC) and predicts poor prognosis. Overexpression of PCK1 has been shown to suppress liver tumor growth, but the underlying mechanism remains unclear. mRNA and protein expression patterns of PCK1, AMPK, pAMPK, and the CDK/Rb/E2F pathway were determined using qRT-PCR and western blotting. Cell proliferation ability and cell cycle were assessed by MTS assay and flow cytometric analysis. The effect of PCK1 on tumor growth was examined in xenograft implantation models. Both gain and loss-of-function experiments demonstrated that PCK1 deficiency promotes hepatoma cell proliferation through inactivation of AMPK, suppression of p27 Kip1 expression, and stimulation of the CDK/Rb/E2F pathway, thereby accelerating cell cycle transition from the G1 to S phase under glucose-starved conditions. Overexpression of PCK1 reduced cellular ATP levels and enhanced AMPK phosphorylation and p27 Kip1 expression but decreased Rb phosphorylation, leading to cell cycle arrest at G1. AMPK knockdown significantly reversed G1-phase arrest and growth inhibition of PCK1-expressing SK-Hep1 cells. In addition, the AMPK activator metformin remarkably suppressed the growth of PCK1-knockout PLC/PRF/5 cells and inhibited tumor growth in an orthotropic HCC mouse model. This study revealed that PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27 Kip1 axis and supports a potential therapeutic and protective effect of metformin on HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13046-019-1029-y

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Suppression of PCK1 expression promotes cell proliferation by inducing G1/S phase transition in hepatoma cells. a-d Cell proliferation curves and colony formation assay. a, b SK-Hep1 and MHCC-97H cells were infected with adenoviruses expressing PCK1 or GFP control. PCK1 overexpression (PCK1-OE) was confirmed by western blotting. c, d Endogenous PCK1 was knocked out in PRF/PLC/5 cells by CRISPR-Cas9 and confirmed by western blotting. Cells were seeded into 96-well plates at 1 × 103 cells/mL and counted every 24 h in triplicate for cell proliferation analysis. Cells were seeded in 6-well plates at 1 × 103 cells/well and cultured for 2 weeks for colony formation assays. e, f Flow cytometric analysis. e PCK1-OE SK-Hep1 cells and f PCK1-KO cells were collected at different time points and subjected to flow cytometry. Populations of cells at G1 and S phases are indicated as percentages of the whole cell population. Data represent the mean ± SD of three independent experiments; (means ± SD; *P < 0.05, **P < 0.01)
Fig. 1 Suppression of PCK1 expression promotes cell proliferation by inducing G1/S phase transition in hepatoma cells. a-d Cell proliferation curves and colony formation assay. a, b SK-Hep1 and MHCC-97H cells were infected with adenoviruses expressing PCK1 or GFP control. PCK1 overexpression (PCK1-OE) was confirmed by western blotting. c, d Endogenous PCK1 was knocked out in PRF/PLC/5 cells by CRISPR-Cas9 and confirmed by western blotting. Cells were seeded into 96-well plates at 1 × 103 cells/mL and counted every 24 h in triplicate for cell proliferation analysis. Cells were seeded in 6-well plates at 1 × 103 cells/well and cultured for 2 weeks for colony formation assays. e, f Flow cytometric analysis. e PCK1-OE SK-Hep1 cells and f PCK1-KO cells were collected at different time points and subjected to flow cytometry. Populations of cells at G1 and S phases are indicated as percentages of the whole cell population. Data represent the mean ± SD of three independent experiments; (means ± SD; *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 2 PCK1 controls the expression of cell cycle-related genes. a Heat map representing the differential expression of E2F family members, transcription factors, and E2F target genes as determined by RNA-Seq in PCK1-OE and GFP control cells. Hepatoma cells infected with adenoviruses expressing PCK1 (AdPCK1) or vector control (AdGFP) were subjected to RNA-Seq analysis. b–e Differentially expressed genes (DEGs) were validated in PCK1-OE and PCK1-KO hepatoma cells by RT-qPCR and western blot analysis. PCK1-OE SK-Hep1 cells and PCK1-KO cells were treated as described in Fig. 1. b, c mRNA expression levels of the indicated genes were measured by qRT-PCR. d, e Western blot analysis of the indicated genes in PCK1-OE and PCK1-KO cells. β-actin was used as a loading control. Relative levels of target proteins were measured by densitometry. Data are presented as the mean ± SD of three independent experiments; *P < 0.05, **P < 0.01
Fig. 2 PCK1 controls the expression of cell cycle-related genes. a Heat map representing the differential expression of E2F family members, transcription factors, and E2F target genes as determined by RNA-Seq in PCK1-OE and GFP control cells. Hepatoma cells infected with adenoviruses expressing PCK1 (AdPCK1) or vector control (AdGFP) were subjected to RNA-Seq analysis. b–e Differentially expressed genes (DEGs) were validated in PCK1-OE and PCK1-KO hepatoma cells by RT-qPCR and western blot analysis. PCK1-OE SK-Hep1 cells and PCK1-KO cells were treated as described in Fig. 1. b, c mRNA expression levels of the indicated genes were measured by qRT-PCR. d, e Western blot analysis of the indicated genes in PCK1-OE and PCK1-KO cells. β-actin was used as a loading control. Relative levels of target proteins were measured by densitometry. Data are presented as the mean ± SD of three independent experiments; *P < 0.05, **P < 0.01CC BY · PubMed Central
Fig. 3 PCK1 activates AMPK by decreasing ATP levels in glucose-deprived hepatoma cells. a–d Immunoblot analysis of AMPK and phosphorylated AMPK. (a) PCK1-OE or (b) PCK1-KO hepatoma cells were cultured in normal DMEM for 1, 3, 5, or 7 days, while (c) PCK1-OE or (d) PCK1-KO hepatoma cells were cultured in DMEM containing different concentrations of glucose (25 or 1 mM) for 12 h. AMPK phosphorylation was measured by western blot analysis. Results are representative of three independent experiments. e, f Protein expression of LKB1 and CaMKK2 in (e) PCK1-OE and (f) PCK1-KO hepatoma cells. β-actin was used as a loading control. Integrated density of pAMPK/AMPK, LKB1, and CaMKK2 was quantitatively analyzed using ImageJ software and the results were normalized to mock or parental group. *P < 0.05, **P < 0.01. (g, h) Quantification of ATP concentrations in (g) PCK1-OE and (h) PCK1-KO HCC cells cultured in normal DMEM medium for 1, 3, 5, or 7 days. Cellular ATP levels were determined as described in the Methods section. Values represent mean ATP/protein levels ± SD of triplicate samples. *P < 0.05, **P < 0.01
Fig. 3 PCK1 activates AMPK by decreasing ATP levels in glucose-deprived hepatoma cells. a–d Immunoblot analysis of AMPK and phosphorylated AMPK. (a) PCK1-OE or (b) PCK1-KO hepatoma cells were cultured in normal DMEM for 1, 3, 5, or 7 days, while (c) PCK1-OE or (d) PCK1-KO hepatoma cells were cultured in DMEM containing different concentrations of glucose (25 or 1 mM) for 12 h. AMPK phosphorylation was measured by western blot analysis. Results are representative of three independent experiments. e, f Protein expression of LKB1 and CaMKK2 in (e) PCK1-OE and (f) PCK1-KO hepatoma cells. β-actin was used as a loading control. Integrated density of pAMPK/AMPK, LKB1, and CaMKK2 was quantitatively analyzed using ImageJ software and the results were normalized to mock or parental group. *P < 0.05, **P < 0.01. (g, h) Quantification of ATP concentrations in (g) PCK1-OE and (h) PCK1-KO HCC cells cultured in normal DMEM medium for 1, 3, 5, or 7 days. Cellular ATP levels were determined as described in the Methods section. Values represent mean ATP/protein levels ± SD of triplicate samples. *P < 0.05, **P < 0.01CC BY · PubMed Central
Fig. 4 PCK1-mediated AMPK activation and delayed cell proliferation depend on p27Kip1 expression and phosphorylation of Rb protein. a, b Protein levels of the indicated proteins in PCK1-OE and KO hepatoma cells. β-actin was used as a loading control. a AMPK-stable knockdown SK-Hep1 cells (SK-Hep1/shAMPK) or control cells (SK-Hep1/shControl) were infected with AdPCK1 or AdGFP for 48 h, respectively. b PCK1-KO or parental PLC/PRF/5 cells were treated with 5 mM metformin for 12 h. Cell lysates were then subjected to immunoblot assays with the indicated antibodies for detecting the protein expression levels of p27Kip1, pRB, AMPK, and pAMPK. Results shown are representative samples from at least three independent experiments. Integrated density of these proteins was quantitatively analyzed and the results normalized to the shCon+AdGFP or parental group. c, d Flow cytometric analysis. Cells were treated as described above, collected at different timepoints (1, 2, 3, 4, or 5 days), and subjected to flow cytometry. Percentages of cells in the G1 and S phases are shown within each graph. Data represent the mean ± SD of three independent experiments. *P < 0.05. e–h Cell proliferation curves and colony formation assay. SK-Hep1 cells infected with shAMPK or shControl lentivirus were treated as described in a while PCK1-KO and parental PLC/PRF/5 cells were treated with 0.5 mM metformin. e, f Representative images and quantification of colony formation. Cell colonies were counted after 2 weeks of incubation. g, h Cell proliferation curves. Cells were counted every 24 h in triplicate. Values represent the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01
Fig. 4 PCK1-mediated AMPK activation and delayed cell proliferation depend on p27Kip1 expression and phosphorylation of Rb protein. a, b Protein levels of the indicated proteins in PCK1-OE and KO hepatoma cells. β-actin was used as a loading control. a AMPK-stable knockdown SK-Hep1 cells (SK-Hep1/shAMPK) or control cells (SK-Hep1/shControl) were infected with AdPCK1 or AdGFP for 48 h, respectively. b PCK1-KO or parental PLC/PRF/5 cells were treated with 5 mM metformin for 12 h. Cell lysates were then subjected to immunoblot assays with the indicated antibodies for detecting the protein expression levels of p27Kip1, pRB, AMPK, and pAMPK. Results shown are representative samples from at least three independent experiments. Integrated density of these proteins was quantitatively analyzed and the results normalized to the shCon+AdGFP or parental group. c, d Flow cytometric analysis. Cells were treated as described above, collected at different timepoints (1, 2, 3, 4, or 5 days), and subjected to flow cytometry. Percentages of cells in the G1 and S phases are shown within each graph. Data represent the mean ± SD of three independent experiments. *P < 0.05. e–h Cell proliferation curves and colony formation assay. SK-Hep1 cells infected with shAMPK or shControl lentivirus were treated as described in a while PCK1-KO and parental PLC/PRF/5 cells were treated with 0.5 mM metformin. e, f Representative images and quantification of colony formation. Cell colonies were counted after 2 weeks of incubation. g, h Cell proliferation curves. Cells were counted every 24 h in triplicate. Values represent the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01CC BY · PubMed Central
Fig. 5 PCK1 inhibits hepatoma growth in a subcutaneous xenograft mouse model. MHCC-97H cells were infected with AdGFP or AdPCK1 for 24 h. Control MHCC-97H cells and infected cells (1 × 105 cells/injection) were injected into the flank of nude mice (n = 6 per group). a Tumor growth curves of subcutaneous xenograft tumor model mice. Tumor volumes were calculated as M × (square of W)/2. *P < 0.05 by two-tailed unpaired Student’s t-test. Mice were sacrificed 38 days after injection, followed by xenograft tumor dissection. b Representative images of xenografts tumors. c Tumor size and d tumor weight of subcutaneous xenografts. e PCK1, pAMPK, and p27Kip1 protein expression in tumor tissue samples as detected by western blotting. Relative levels of the indicated proteins were quantified using ImageJ software. **P < 0.01
Fig. 5 PCK1 inhibits hepatoma growth in a subcutaneous xenograft mouse model. MHCC-97H cells were infected with AdGFP or AdPCK1 for 24 h. Control MHCC-97H cells and infected cells (1 × 105 cells/injection) were injected into the flank of nude mice (n = 6 per group). a Tumor growth curves of subcutaneous xenograft tumor model mice. Tumor volumes were calculated as M × (square of W)/2. *P < 0.05 by two-tailed unpaired Student’s t-test. Mice were sacrificed 38 days after injection, followed by xenograft tumor dissection. b Representative images of xenografts tumors. c Tumor size and d tumor weight of subcutaneous xenografts. e PCK1, pAMPK, and p27Kip1 protein expression in tumor tissue samples as detected by western blotting. Relative levels of the indicated proteins were quantified using ImageJ software. **P < 0.01CC BY · PubMed Central
Fig. 6 Metformin suppresses tumor growth in an orthotopic implantation tumor model established with PCK1-KO hepatoma cells. PCK1-KO and parental cells (1 × 105 cells/injection) were implanted into the left lobes of nude mice livers (n = 5 per group). One week after implantation, mice were treated with metformin (250 mg/kg per day, intraperitoneally) or PBS (equal volume, intraperitoneally) for 6 weeks. The mice were sacrificed 7 weeks after implantation. a Schematic overview of the experiment design. b Tumor foci number in the liver of each mouse. c Representative gross appearance of murine livers. Red arrows: metastatic foci. d, e Representative d HE staining and e IHC detection of PCK1 and pAMPK in liver tumor tissues. Magnification: 100×, 200×
Fig. 6 Metformin suppresses tumor growth in an orthotopic implantation tumor model established with PCK1-KO hepatoma cells. PCK1-KO and parental cells (1 × 105 cells/injection) were implanted into the left lobes of nude mice livers (n = 5 per group). One week after implantation, mice were treated with metformin (250 mg/kg per day, intraperitoneally) or PBS (equal volume, intraperitoneally) for 6 weeks. The mice were sacrificed 7 weeks after implantation. a Schematic overview of the experiment design. b Tumor foci number in the liver of each mouse. c Representative gross appearance of murine livers. Red arrows: metastatic foci. d, e Representative d HE staining and e IHC detection of PCK1 and pAMPK in liver tumor tissues. Magnification: 100×, 200×CC BY · PubMed Central
Fig. 7 PCK1 expression is reduced in HCC tissues and is positively correlated with pAMPK and p27Kip1 expression. a, b Correlation between CDKN1B, CCNE1, and PCK1. Correlation between mRNA expression levels of a CDKN1B or b CCNE1 and PCK1 based on data from 371 HCC patients from the TCGA database mRNA dataset. Statistical analysis was performed using Pearson’s correlation coefficient (P < 0.0001). c PCK1, pAMPK, and p27Kip1 protein levels in 20 paired primary HCC tissues and adjacent non-tumor tissues. β-actin was used as a loading control. d Representative IHC images of PCK1 and pAMPK in HCC and adjacent non-tumor tissues. Magnification, 200×. e Proposed model for activation of AMPK and cell cycle arrest in PCK1-induced inhibition of hepatoma cell growth. The gluconeogenic enzyme PCK1 catalyzes an energy-consuming reaction, which consumes GTP to generate GDP. PCK1 induces AMPK activation via ATP-dependent mechanisms both in hepatoma cells and in vivo. AMPK activation further promotes G1/S transition by regulating p27Kip1 expression and negatively modulating pCDK2, cyclin E1, and pRB expression. Eventually, PCK1 inhibits the growth of hepatoma cells and the development of HCC through AMPK activation and cell cycle arrest
Fig. 7 PCK1 expression is reduced in HCC tissues and is positively correlated with pAMPK and p27Kip1 expression. a, b Correlation between CDKN1B, CCNE1, and PCK1. Correlation between mRNA expression levels of a CDKN1B or b CCNE1 and PCK1 based on data from 371 HCC patients from the TCGA database mRNA dataset. Statistical analysis was performed using Pearson’s correlation coefficient (P < 0.0001). c PCK1, pAMPK, and p27Kip1 protein levels in 20 paired primary HCC tissues and adjacent non-tumor tissues. β-actin was used as a loading control. d Representative IHC images of PCK1 and pAMPK in HCC and adjacent non-tumor tissues. Magnification, 200×. e Proposed model for activation of AMPK and cell cycle arrest in PCK1-induced inhibition of hepatoma cell growth. The gluconeogenic enzyme PCK1 catalyzes an energy-consuming reaction, which consumes GTP to generate GDP. PCK1 induces AMPK activation via ATP-dependent mechanisms both in hepatoma cells and in vivo. AMPK activation further promotes G1/S transition by regulating p27Kip1 expression and negatively modulating pCDK2, cyclin E1, and pRB expression. Eventually, PCK1 inhibits the growth of hepatoma cells and the development of HCC through AMPK activation and cell cycle arrestCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 84

Metadata

Authors
Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., Wang, K., & Tang, N.
Affiliations
Second Affiliated Hospital of Chongqing Medical University (CN)
Corresponding author
  • Huang, Ailong
  • Wang, Kai
  • Tang, Ni
Venue
Journal of Experimental & Clinical Cancer Research
Published
2019-02-04
Volume
38
Issue
1
Pages
50-50
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W2921283762
Cited by
84
References
52
Citations by year
2026: 6 · 2025: 13 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 15 · 2020: 8 · 2019: 5
FWCI
3.23
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81602417, 81572683, 81371827, 81872270,31171307, 81471946,81661148057, 81671997)
  • Natural Science Foundation of Chongqing (cstc2015jcyjBX0011, cstc2018jcyjAX0254)
  • Department of S and T for Social Development (2017ZX10202203-004, 2012ZX10002005-003-002)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
PCK1, hepatocellular carcinoma, AMPK, p27, cell cycle progression, cell proliferation, gluconeogenesis, glucose metabolism, metformin, G1 cell cycle arrest, tumor growth
MeSH terms
Animals, Calcium-Binding Proteins, Glucose, Carcinoma, Hepatocellular, Humans, Hypoglycemic Agents, Liver Neoplasms, Male, Metformin, Phosphoenolpyruvate Carboxykinase (GTP), Down-Regulation, Up-Regulation, Cyclin-Dependent Kinases, Xenograft Model Antitumor Assays, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Cell Proliferation, E2F Transcription Factors, Mice, AMP-Activated Protein Kinases, Gene Knockdown Techniques, G1 Phase Cell Cycle Checkpoints

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. https://app.cochat.ai/papers/10.1186/s13046-019-1029-y
The paper
Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., Wang, K., & Tang, N. (2019). PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-019-1029-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.